SMAD3 and type 1 diabetes mellitus: In addition, Smad3-deficient mice demonstrated reduction in both renal and cardiac fibrosis in STZ-induced type 1 diabetes and in obese diabetic mice (Wang et al., 2007; Biernacka et al., 2015).